The antidepressant-like effect of vagus nerve stimulation is mediated through the locus coeruleus.

It has been shown that vagus nerve stimulation (VNS) has an antidepressant-like effect in the forced swim test. The mechanism of action underlying this effect is incompletely understood, but there is evidence suggesting that the locus coeruleus (LC) may play an important role. In this study, noradrenergic LC neurons were selectively lesioned to test their involvement in the antidepressant-like effect of VNS in the forced swim test. Forced swim test behavior was assessed in rats that were subjected to VNS or sham treatment. In half of the VNS-treated animals, the noradrenergic neurons from the LC were lesioned using the selective neurotoxin DSP-4 [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride], yielding three experimental arms: sham, VNS and DSP-4-VNS (n = 8 per group). Furthermore, the open field test was performed to evaluate locomotor activity. A dopamine-β-hydroxylase immunostaining was performed to confirm lesioning of noradrenergic LC neurons. VNS significantly reduced the percentage of immobility time in the forced swim test compared to sham treatment (median: 56%, interquartile range: 41% vs. median: 75%, interquartile range: 12%). This antidepressant-like effect of VNS could not be demonstrated in the DSP-4-VNS group (median: 79%, interquartile range: 33%). Locomotor activity in the open field test was not different between the three treatment arms. The absence of hippocampal dopamine-β-hydroxylase immunostaining in the DSP-4-treated rats confirmed the lesioning of noradrenergic neurons originating from the brainstem LC. The results of this study demonstrate that the noradrenergic neurons from the LC play an important role in the antidepressant-like effect of VNS.

[1]  Zul Merali,et al.  Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions. , 2008, The international journal of neuropsychopharmacology.

[2]  M. Sperling,et al.  Vagal nerve stimulation: Adjustments to reduce painful side effects , 2001, Neurology.

[3]  S. Krahl,et al.  Vagus nerve stimulation for epilepsy: A review of central mechanisms , 2012, Surgical neurology international.

[4]  R. Moore,et al.  Noradrenergic innervation of the adult rat hippocampal formation , 1980, The Journal of comparative neurology.

[5]  A. Rush,et al.  Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. , 2005, The Journal of clinical psychiatry.

[6]  A. Frazer,et al.  Serotonergic and Noradrenergic Pathways Are Required for the Anxiolytic-like and Antidepressant-like Behavioral Effects of Repeated Vagal Nerve Stimulation in Rats , 2011, Biological Psychiatry.

[7]  G. Debonnel,et al.  Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation. , 2009, Journal of psychiatry & neuroscience : JPN.

[8]  Cole A. Giller,et al.  Vagus Nerve Stimulation (VNS™) for Treatment-Resistant Depression: Efficacy, Side Effects, and Predictors of Outcome , 2001, Neuropsychopharmacology.

[9]  G. Aston-Jones,et al.  Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus , 1996, Brain Research.

[10]  T. Svensson,et al.  Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. , 1993, European journal of pharmacology.

[11]  Michael L. Levy,et al.  Vagus Nerve Stimulation , 2008, Proceedings of the IEEE.

[12]  R. Roth,et al.  Tricyclic antidepressants: effects on the firing rate of brain noradrenergic neurons. , 1975, European journal of pharmacology.

[13]  J. Fritschy,et al.  Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals , 1989, Neuroscience.

[14]  Barry R. Rittberg,et al.  Effects of 12 Months of Vagus Nerve Stimulation in Treatment-Resistant Depression: A Naturalistic Study , 2005, Biological Psychiatry.

[15]  L. Price,et al.  Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients , 2004, Biological Psychiatry.

[16]  M. Page,et al.  Activation of the locus ceruleus brain noradrenergic system during stress: circuitry, consequences, and regulation. , 1998, Advances in pharmacology.

[17]  L. Galea,et al.  The Neural Plasticity Theory of Depression: Assessing the Roles of Adult Neurogenesis and PSA-NCAM within the Hippocampus , 2013, Neural plasticity.

[18]  Edith Hamel,et al.  Locus Coeruleus Stimulation Recruits a Broad Cortical Neuronal Network and Increases Cortical Perfusion , 2013, The Journal of Neuroscience.

[19]  Barry R. Rittberg,et al.  A One-Year Comparison of Vagus Nerve Stimulation with Treatment as Usual for Treatment-Resistant Depression , 2005, Biological Psychiatry.

[20]  V. Brown,et al.  Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat , 2005, Neuroscience Letters.

[21]  M. Briley,et al.  The importance of norepinephrine in depression , 2011, Neuropsychiatric disease and treatment.

[22]  I. Lucki,et al.  Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. , 2002, European journal of pharmacology.

[23]  A. Randich,et al.  Electrical stimulation of cervical vagal afferents. I. Central relays for modulation of spinal nociceptive transmission. , 1990, Journal of neurophysiology.

[24]  R. Raedt,et al.  Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model , 2011, Journal of neurochemistry.

[25]  S. Krahl,et al.  Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. , 2004, Journal of psychiatric research.

[26]  A. Randich,et al.  Electrical stimulation of cervical vagal afferents. II. Central relays for behavioral antinociception and arterial blood pressure decreases. , 1990, Journal of neurophysiology.

[27]  J. Fritschy,et al.  Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system? , 1991, Progress in brain research.

[28]  W. Maier,et al.  Two-Year Outcome of Vagus Nerve Stimulation in Treatment-Resistant Depression , 2010, Journal of clinical psychopharmacology.

[29]  C. Nemeroff,et al.  The role of dopamine in the pathophysiology of depression. , 2007, Archives of general psychiatry.

[30]  Christian E Elger,et al.  Vagus nerve stimulation is associated with mood improvements in epilepsy patients , 2000, Epilepsy Research.

[31]  W. Paré Stress ulcer susceptibility and depression in Wistar Kyoto (WKY) rats , 1989, Physiology & Behavior.

[32]  Karl Deisseroth,et al.  High-Speed Imaging Reveals Neurophysiological Links to Behavior in an Animal Model of Depression , 2007, Science.

[33]  A. Dorr,et al.  Effect of Vagus Nerve Stimulation on Serotonergic and Noradrenergic Transmission , 2006, Journal of Pharmacology and Experimental Therapeutics.

[34]  G. Aston-Jones,et al.  Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat , 2005, Journal of Neural Transmission / General Section JNT.

[35]  J. Scuvée-Moreau,et al.  Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat. , 1979, European journal of pharmacology.

[36]  Cedric L. Williams,et al.  The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala. , 2004, Behavioral neuroscience.

[37]  Alfred Meurs,et al.  Vagus Nerve Stimulation has Antidepressant Effects in the Kainic Acid Model for Temporal Lobe Epilepsy , 2015, Brain Stimulation.

[38]  H. Sackeim,et al.  Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes , 2002, Biological Psychiatry.

[39]  Ronald S Duman,et al.  Regulation of Adult Neurogenesis by Antidepressant Treatment , 2001, Neuropsychopharmacology.

[40]  D. Labar,et al.  Vagus nerve stimulation for 1 year in 269 patients on unchanged antiepileptic drugs , 2004, Seizure.

[41]  W. Danysz,et al.  On the role of noradrenergic neurotransmission in the action of desipramine and amitriptyline in animal models of depression. , 1986, Polish journal of pharmacology and pharmacy.

[42]  B. K. Hartman,et al.  The use of dopamine -hydroxylase as a marker for the central noradrenergic nervous system in rat brain. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Robert Goodman,et al.  Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study∗ ∗ See accompanying Editorial, in this issue. , 2000, Biological Psychiatry.

[44]  Mustafa M. Husain,et al.  Vagus Nerve Stimulation for Treatment-Resistant Depression: A Randomized, Controlled Acute Phase Trial , 2005, Biological Psychiatry.

[45]  E. Ben-Menachem,et al.  Evidence-based guideline update: Vagus nerve stimulation for the treatment of epilepsy , 2013, Neurology.

[46]  W. Maier,et al.  Vagus nerve stimulation for depression: efficacy and safety in a European study , 2008, Psychological Medicine.

[47]  J. Harro,et al.  Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus , 2001, Brain Research Reviews.

[48]  F. Marrosu,et al.  Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain , 2007, Brain Research.

[49]  M. Ruberg,et al.  The Alpha2-Adrenoceptor Antagonist Dexefaroxan Enhances Hippocampal Neurogenesis by Increasing the Survival and Differentiation of New Granule Cells , 2006, Neuropsychopharmacology.

[50]  J. O'reardon,et al.  Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year. , 2011, The Journal of clinical psychiatry.

[51]  E. Ben-Menachem,et al.  Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation , 2008, Experimental Neurology.

[52]  R. Porsolt,et al.  Behavioural despair in rats: a new model sensitive to antidepressant treatments. , 1978, European journal of pharmacology.

[53]  L. Nandam,et al.  Norepinephrine Directly Activates Adult Hippocampal Precursors via β3-Adrenergic Receptors , 2010, The Journal of Neuroscience.

[54]  G. Debonnel,et al.  Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems. , 2013, The international journal of neuropsychopharmacology.

[55]  P. Blier,et al.  Novel attempts to optimize vagus nerve stimulation parameters on serotonin neuronal firing activity in the rat brain , 2012, Brain Stimulation.

[56]  E. Hamel,et al.  Journal of Cerebral Blood Flow and Metabolism Astroglial and Vascular Interactions of Noradrenaline Terminals in the Rat Cerebral Cortex , 2022 .

[57]  Douglas C. Smith,et al.  Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat , 2006, Brain Research.

[58]  S. Krahl,et al.  Locus Coeruleus Lesions Suppress the Seizure‐Attenuating Effects of Vagus Nerve Stimulation , 1998, Epilepsia.

[59]  Maurizio Fava,et al.  Diagnosis and definition of treatment-resistant depression , 2003, Biological Psychiatry.

[60]  F. Carreño,et al.  Vagal Nerve Stimulation Rapidly Activates Brain-Derived Neurotrophic Factor Receptor TrkB in Rat Brain , 2012, PloS one.

[61]  C. Nemeroff,et al.  Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. , 1994, Clinical chemistry.

[62]  A. Randich,et al.  Vagal afferent modulation of nociception , 1992, Brain Research Reviews.

[63]  W. Danysz,et al.  Studies on the locus coeruleus system in an animal model for antidepressive activity. , 1984, Polish journal of pharmacology and pharmacy.

[64]  R. Porsolt,et al.  Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.

[65]  A. Bidziński,et al.  Evidence for existence of two opposite noradrenergic brain systems controlling behavior , 1978, Psychopharmacology.

[66]  Vagus nerve stimulation ameliorated deficits in one-way active avoidance learning and stimulated hippocampal neurogenesis in bulbectomized rats , 2013, Brain Stimulation.

[67]  Yogesh K. Dwivedi,et al.  Hippocampal neurogenesis, neurotrophic factors and depression: possible therapeutic targets? , 2015, CNS & neurological disorders drug targets.

[68]  J. Schildkraut,et al.  The catecholamine hypothesis of affective disorders: a review of supporting evidence. , 1965, The American journal of psychiatry.

[69]  D. Slattery,et al.  Using the rat forced swim test to assess antidepressant-like activity in rodents , 2012, Nature Protocols.

[70]  Olga V. Demler,et al.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.

[71]  R. Valentino,et al.  Antidepressant actions on brain noradrenergic neurons. , 1990, The Journal of pharmacology and experimental therapeutics.

[72]  C. Harden Depression and anxiety in epilepsy patients , 2002, Epilepsy & Behavior.

[73]  F. Marrosu,et al.  Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus. , 2009, The international journal of neuropsychopharmacology.